- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 5.60 Å
- Oligo State
- hetero-1-1-1-1-1-1-18-mer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 37 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.22: 2 residues within 4Å:- Chain E: N.407, S.409
Ligand excluded by PLIPNAG.23: 5 residues within 4Å:- Chain G: E.209, T.211, N.256, T.258, D.355
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain E: S.365, D.367
- Chain G: N.213, N.215, S.252
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain H: N.213, N.215, F.251, S.252
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain H: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain I: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain I: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain J: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain J: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.31: 5 residues within 4Å:- Chain K: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain K: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain L: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.34: 5 residues within 4Å:- Chain L: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.35: 5 residues within 4Å:- Chain M: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain M: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain N: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.38: 6 residues within 4Å:- Chain M: N.380
- Chain N: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain O: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.40: 6 residues within 4Å:- Chain N: N.380
- Chain O: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.41: 5 residues within 4Å:- Chain P: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain P: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain Q: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.44: 6 residues within 4Å:- Chain P: N.380
- Chain Q: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.45: 5 residues within 4Å:- Chain R: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.46: 6 residues within 4Å:- Chain Q: N.380
- Chain R: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.47: 5 residues within 4Å:- Chain S: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.48: 5 residues within 4Å:- Chain S: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.49: 5 residues within 4Å:- Chain T: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.50: 5 residues within 4Å:- Chain T: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.51: 5 residues within 4Å:- Chain U: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.52: 5 residues within 4Å:- Chain U: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.53: 5 residues within 4Å:- Chain V: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.54: 5 residues within 4Å:- Chain V: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.55: 5 residues within 4Å:- Chain W: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.56: 5 residues within 4Å:- Chain W: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.57: 5 residues within 4Å:- Chain X: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.58: 5 residues within 4Å:- Chain X: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Menny, A. et al., CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. Nat Commun (2018)
- Release Date
- 2018-12-19
- Peptides
- Complement C5,Complement C5: A
Complement component C8 beta chain: B
Complement component C7: C
Complement component C8 gamma chain: D
Complement component C8 alpha chain: E
Complement component C6: F
Complement component C9: GHIJKLMNOPQRSTUVWX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
DD
EE
FF
BG
GH
PI
HJ
IK
JL
KM
LN
MO
NP
OQ
QR
RS
ST
TU
UV
VW
WX
X
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 5.60 Å
- Oligo State
- hetero-1-1-1-1-1-1-18-mer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 37 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Menny, A. et al., CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. Nat Commun (2018)
- Release Date
- 2018-12-19
- Peptides
- Complement C5,Complement C5: A
Complement component C8 beta chain: B
Complement component C7: C
Complement component C8 gamma chain: D
Complement component C8 alpha chain: E
Complement component C6: F
Complement component C9: GHIJKLMNOPQRSTUVWX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
DD
EE
FF
BG
GH
PI
HJ
IK
JL
KM
LN
MO
NP
OQ
QR
RS
ST
TU
UV
VW
WX
X